4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-24-050835
Options or other derivatives
- Director acquired 7,688 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Moukheibir Catherine · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-06 | Grant or award : show line 1 in the form Option to Buy | +7,688 | 7,688 | D |
Loading xslF345X05/ownership.xml…